Parabilis Medicines, Inc. Common Stock (PBLS) — Net Asset Quality Index
Parabilis Medicines, Inc. Common Stock (PBLS) has a Net Asset Quality Index of 89.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.18 Billion minus total liabilities of $127.53 Million yields net assets of $1.05 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Explore PBLS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Parabilis Medicines, Inc. Common Stock Net Asset Quality Index Over Time (2024–2025)
This chart shows how Parabilis Medicines, Inc. Common Stock's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the index stands at 89.1%, representing net assets of $1.05 Billion against total assets of $1.18 Billion USD. See Parabilis Medicines, Inc. Common Stock book value and equity for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Parabilis Medicines, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Net Asset Quality Index for Parabilis Medicines, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PBLS company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -20.4% | $-16.52 Million | $80.82 Million | $97.34 Million | ▼ -58.3 pp |
| 2024 | 37.8% | $56.44 Million | $149.25 Million | $92.81 Million | — |